Millennium Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Millennium Management's IHE Position: Q3 2026 in Review
Millennium Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 3,565 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #5229 among its holdings. This is a return to the name: Millennium Management previously reported a position in IHE as recently as Q3 2015.
Millennium Management first reported a position in IHE in Q1 2015 and has held it in 4 quarters since. The position peaked at $641K in Q1 2015. 248 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Millennium Management held 3,565 shares of iShares US Pharmaceuticals ETF worth $358K as of Q3 2026.
- iShares US Pharmaceuticals ETF was a new Millennium Management position in Q3 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5229 holding.
- Millennium Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 4 quarters since.
- Millennium Management's iShares US Pharmaceuticals ETF position peaked at $641K in Q1 2015.
- 248 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.